“We're going to Examine how the commercialization of this substance matches in with our business design at Adastra in order to situation ourselves to help the need for a secure supply of copyright,” explained chief executive officer Michael Forbes in a information launch. The corporate told VICE News it would not be commenting even further.CIPA